Esterases

03/01/1969 - "[Enzymographic studies on non-specific esterases in human cerebral tumors]."
03/01/1967 - "[Studies on serum esterases in cancer. "
01/01/1963 - "[HISTOCHEMICAL STUDIES ON THE ACTIVITY OF UNSPECIFIC ESTERASES IN TRANSPLANTABLE TUMORS]."
01/01/2014 - "Esterases are often overexpressed in cancer cells and can have chiral specificities different from that of the corresponding normal tissues. "
02/01/2003 - "Analogue 11, whist neither a PP1 nor a PP2A inhibitor shows anti-cancer activity comparable to 1 and 2. We believe that intracellular esterases generate the corresponding dicarboxylate, which is a potent PP1 and PP2A inhibitor, and that it is this species which is responsible for the observed anti-cancer activity."

09/01/2008 - "Plasma esterases and inflammation in ageing and frailty."
09/15/1978 - "Column chromatography of extracts and secretions of the pancreas as well as of sera from patients suffering from inflammations of this organ yields three esterases different from each other in molecular size. "
04/01/1961 - "Certain aryloxypropionates and anti-esterases were also active in reducing the severity of the formaldehyde-induced inflammation."
03/05/2015 - "Caffeic acid phenethyl ester, a natural phenolic compound, possesses antifibrotic, anti-inflammation and anti-oxidative stress effects; however, rapid decomposition by esterases substantially decreases its bioavailability. "
01/01/1972 - "[Cytochemical characteristics of the aseptic inflammation type foreign body (cytochemical studies of some enzymes from the group of oxidoreductases and esterases)]."

02/01/1979 - "We found that: (1) the ability of the muscle to sustain tetanus in response to nerve stimulation is eliminated when the esterases at the neuromuscular junctions are saturated with DFP. "

02/01/2003 - "Complete remission rates in patients with myasthenia gravis (MG) using anticholine esterases, immunosuppressive drugs, and medical therapy methods like plasmapheresis are low. "

01/01/1987 - "Cytochemical, electrophoretic and chromatographic studies of non-specific esterases in acute myeloid leukemia."
06/01/2004 - "The t(8;16)(p11;p13) fuses the MOZ (MYST3) gene at 8p11 with CBP (CREBBP) at 16p13 and is associated with an infrequent but well-defined type of acute myeloid leukemia (AML) that has unique morphocytochemical findings (monocytoid blast morphology with erythrophagocytosis and simultaneously positive for myeloperoxidase and nonspecific esterases). "
01/03/1983 - "In acute myeloid leukemia the three esterases appear in parallel at a somewhat later stage of maturation than myeloperoxidase. "
03/01/1984 - "Alpha-naphthyl acetate esterases (ANAE) were examined by cytochemical and isoelectric focusing (IEF) techniques in 48 cases of acute myeloid leukemia that were classified by conventional morphological criteria. "
03/01/1984 - "Electrophoretic and cytochemical characterization of alpha-naphthyl acetate esterases in acute myeloid leukemia: relationships with membrane receptor and monocyte-specific antigen expression."